Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic

by Scott Gottlieb

“Most biotech companies prepare for disruptions in manufacturing by freezing and stockpiling enough of their most profitable drugs to last about two years. Why not pay these plants to use their capacity for antibody production?